Immuno Oncology Assays Market: Global Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017 to 2021 and Forecast 2022 to 2028

$ PRICE - $ 3,000.00$ 8,900.00

Immuno Oncology Assays Market: By Product Type (Instruments, Reagents and Kits, Software and Services) Technology (Immunoassay, Polymerase chain reaction (PCR), Next-generation sequencing (NGS), Flow Cytometry Others) Indication (Breast Cancer, Colorectal Cancer, Lung Cancer, Melanoma Cancer, Bladder Cancer Others) Application (Clinical Diagnostics, Research Application) and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Category:

Report

Description

Immuno Oncology Assays Market size is valued at USD 2,798.6 million in 2021 and is expected to grow at a prominent growth rate 12.5% during the forecast period 2022 to 2028. The global market provides a detailed overview of the global Immuno Oncology Assays Market, and that can be segmented by Product Type, by Technology, by Indication, and by Application. By product type, the global Immuno Oncology Assays Market has been segmented into Instruments, Reagents and Kits, Software and Services. The software & services segment is likely to be the largest and fastest-growing segment in terms of type. Based on technology, the global Immuno Oncology Assays Market is segmented into Immunoassay, Polymerase chain reaction (PCR), Next-generation sequencing (NGS), Flow Cytometry Others. Among these, the Polymerase chain reaction (PCR) segment is expected to have the fastest-growing market during the forecast period 2022-2028. Based on indication, the global Immuno Oncology Assays Market is segmented into Breast Cancer, Colorectal Cancer, Lung Cancer Treatment, Melanoma Cancer, Bladder Cancer, Others. The lung cancer segment accounts for the largest share in 2021. Breast cancer segment is the second-largest share during the forecast period 2022-2028. Based on the Application, the segment has been segregated into Clinical Diagnostics, Research Application. The clinical diagnostics segment is expected to dominate other segments in the global Immuno Oncology Assays Market. Research application segment is expected to witness the highest CAGR during the forecast period according to precision business insights.

Key Developments:

In July 2020, The HTG EdgeSeq Pan B-Cell Lymphoma Panel was launched by HTG Molecular Diagnostics, Inc. (US).

Immuno Oncology Assays Market

MARKET SUMMARY
-
12.5%
  • Study Period– 2022-2028
  • Base Year– 2021
  • CAGR– 12.5%
  • Largest Market– North American
  • Fastest Growing Market– Asia-Pacific

Immuno Oncology Assays Market

  • The immuno oncology assays market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • The immuno oncology assays market is segmented based on product type, technology, indication, application and geography.
Key Players
  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific, Inc.
  • Illumina, Inc.
  • PerkinElmer, Inc.
  • Crown Bioscience Inc.
Immuno Oncology Assays Market Drivers

In order to diagnose and cure cancer, there is a great demand for research, and immuno-oncology assays play a significant role in this research due to the rise in incidence and prevalence of the disease is burgeon the market growth over the forecast years.


North America Got Significant Share

Immuno Oncology Assays Market

North America held the largest share and is expected to witness the highest market share during the forecast period. It holds a tremendous potential market for global immuno oncology due to the increasing prevalence of cancers and demand for personalized medicine.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The Immuno oncology assays market provides granular level information about the market size, regional market share, historic market (2017-2021) and forecast (2022-2028)
  • The Immuno oncology assays market covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The Immuno oncology assays market outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The Immuno oncology assays market tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The Immuno oncology assays market provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Immuno Oncology Assays Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

The global Immuno Oncology Assays Market size is valued at USD 2,798.6 million in 2021 and is expected to grow at a prominent growth rate during the forecast period 2022 to 2028.

Based on technology, the global Immuno Oncology Assays Market is segmented into Immunoassay, Polymerase chain reaction (PCR), Next-generation sequencing (NGS), Flow Cytometry Others. Among these, the Polymerase chain reaction (PCR) segment is expected to have the fastest-growing market during the forecast period 2022-2028

The key market players are Thermo Fisher Scientific, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Agilent Technologies, Inc. (US), Illumina, Inc. (US), NanoString Technologies, Inc. (US), Sartorius AG(Germany), HTG Molecular Diagnostics, Inc. (US), QIAGEN N.V. (Netherlands), Merck Millipore (US), PerkinElmer, Inc. (US), Abbott Laboratories, Inc. (US), Guardant Health, Inc. (US), bioMérieux SA


Report

Table Of Content

1. Executive Summary
2. Global Immuno Oncology Assays Market Introduction
2.1. Global Immuno Oncology Assays Market – Taxonomy
2.2. Global Immuno Oncology Assays Market –Definitions
2.2.1. By Product Type
2.2.2. By Technology
2.2.3. By Indication
2.2.4. By Application
2.2.5. By Region
3. Global Immuno Oncology Assays Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Immuno Oncology Assays Market Dynamic Factors – Impact Analysis
3.6. Global Immuno Oncology Assays Market – Competition Landscape
4. Global Immuno Oncology Assays Market Analysis, 2017-2021 and Forecast, 2022-2028
4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Immuno Oncology Assays Market, By Product Type, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1. Instruments
5.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Reagents and Kits
5.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Software and Services
5.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
6. Global Immuno Oncology Assays Market, By Technology, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1. Immunoassay
6.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Polymerase chain reaction (PCR)
6.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Next-generation sequencing (NGS)
6.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Flow Cytometry
6.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Others
6.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
7. Global Immuno Oncology Assays Market, By Indication, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1. Breast Cancer
7.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Colorectal Cancer
7.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Lung Cancer
7.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Melanoma Cancer
7.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Bladder Cancer
7.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
7.6. Others
7.6.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.6.3. Market Opportunity Analysis
8. Global Immuno Oncology Assays Market, By Application, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.1. Clinical Diagnostics
8.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Research Application
8.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
9. Global Immuno Oncology Assays Market Forecast, By Region, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.1. North America
9.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
9.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.5.3. Market Opportunity Analysis
9.6. Global Immuno Oncology Assays Market – Opportunity Analysis Index, By Product Type, Technology, Indication, Application, and Region, 2022-2028
10. North America Immuno Oncology Assays Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
10.1. Product Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Instruments
10.1.2. Reagents and Kits
10.1.3. Software and Services
10.2. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.2.1. Immunoassay
10.2.2. Polymerase chain reaction (PCR)
10.2.3. Next-generation sequencing (NGS)
10.2.4. Flow Cytometry
10.2.5. Others
10.3. Indication Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Breast Cancer
10.3.2. Colorectal Cancer
10.3.3. Lung Cancer
10.3.4. Melanoma Cancer
10.3.5. Bladder Cancer
10.3.6. Others
10.4. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.4.1. Clinical Diagnostics
10.4.2. Research Application
10.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.5.1. USA
10.5.2. Canada
10.6. North America Immuno Oncology Assays Market – Opportunity Analysis Index, By Product Type, Technology, Indication, Application, and Country, 2022-2028
10.7. North America Immuno Oncology Assays Market Dynamics – Trends
11. Europe Immuno Oncology Assays Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
11.1. Product Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Instruments
11.1.2. Reagents and Kits
11.1.3. Software and Services
11.2. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. Immunoassay
11.2.2. Polymerase chain reaction (PCR)
11.2.3. Next-generation sequencing (NGS)
11.2.4. Flow Cytometry
11.2.5. Others
11.3. Indication Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Breast Cancer
11.3.2. Colorectal Cancer
11.3.3. Lung Cancer
11.3.4. Melanoma Cancer
11.3.5. Bladder Cancer
11.3.6. Others
11.4. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.4.1. Clinical Diagnostics
11.4.2. Research Application
11.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.5.1. Germany
11.5.2. UK
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Russia
11.5.7. Rest of Europe
11.6. Europe Immuno Oncology Assays Market – Opportunity Analysis Index, By Product Type, Technology, Indication, Application, and Country, 2022-2028
11.7. Europe Immuno Oncology Assays Market Dynamics – Trends
12. Asia-Pacific Immuno Oncology Assays Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
12.1. Product Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Instruments
12.1.2. Reagents and Kits
12.1.3. Software and Services
12.2. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. Immunoassay
12.2.2. Polymerase chain reaction (PCR)
12.2.3. Next-generation sequencing (NGS)
12.2.4. Flow Cytometry
12.2.5. Others
12.3. Indication Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Breast Cancer
12.3.2. Colorectal Cancer
12.3.3. Lung Cancer
12.3.4. Melanoma Cancer
12.3.5. Bladder Cancer
12.3.6. Others
12.4. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.4.1. Clinical Diagnostics
12.4.2. Research Application
12.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.5.1. China
12.5.2. India
12.5.3. Japan
12.5.4. ASEAN
12.5.5. Australia & New Zealand
12.5.6. Rest of Asia-Pacific
12.6. Asia-Pacific Immuno Oncology Assays Market – Opportunity Analysis Index, By Product Type, Technology, Indication, Application, and Country, 2022-2028
12.7. Asia-Pacific Immuno Oncology Assays Market Dynamics – Trends
13. Latin America Immuno Oncology Assays Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
13.1. Product Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Instruments
13.1.2. Reagents and Kits
13.1.3. Software and Services
13.2. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.2.1. Immunoassay
13.2.2. Polymerase chain reaction (PCR)
13.2.3. Next-generation sequencing (NGS)
13.2.4. Flow Cytometry
13.2.5. Others
13.3. Indication Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Breast Cancer
13.3.2. Colorectal Cancer
13.3.3. Lung Cancer
13.3.4. Melanoma Cancer
13.3.5. Bladder Cancer
13.3.6. Others
13.4. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.4.1. Clinical Diagnostics
13.4.2. Research Application
13.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Latin America Immuno Oncology Assays Market – Opportunity Analysis Index, By Product Type, Technology, Indication, Application, and Country, 2022-2028
13.7. Latin America Immuno Oncology Assays Market Dynamics – Trends
14. Middle East and Africa Immuno Oncology Assays Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
14.1. Product Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.1. Instruments
14.1.2. Reagents and Kits
14.1.3. Software and Services
14.2. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.2.1. Immunoassay
14.2.2. Polymerase chain reaction (PCR)
14.2.3. Next-generation sequencing (NGS)
14.2.4. Flow Cytometry
14.2.5. Others
14.3. Indication Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.3.1. Breast Cancer
14.3.2. Colorectal Cancer
14.3.3. Lung Cancer
14.3.4. Melanoma Cancer
14.3.5. Bladder Cancer
14.3.6. Others
14.4. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.4.1. Clinical Diagnostics
14.4.2. Research Application
14.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
14.5.1. Gulf Cooperation Council (GCC) Countries
14.5.2. South Africa
14.5.3. Rest of MEA
14.6. MEA Immuno Oncology Assays Market – Opportunity Analysis Index, By Product Type, Technology, Indication, Application, and Country, 2022-2028
14.7. MEA Immuno Oncology Assays Market Dynamics – Trends
15. Competition Landscape
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Key Offerings, Key Developments, Strategies, and SWOT Analysis)
15.2.1. Agilent Technologies, Inc.
15.2.2. Thermo Fisher Scientific, Inc.
15.2.3. PerkinElmer, Inc.
15.2.4. Illumina, Inc.
15.2.5. PerkinElmer, Inc.
15.2.6. Crown Bioscience Inc.
15.2.7. InSphero, Inc.
15.2.8. Merck & Company, Inc.
15.2.9. F.Hoffmann-La Roche Ltd.
15.2.10. HTG Molecular Diagnostics, Inc.
15.2.11. Miltenyi Biotec
16. Research Methodology
17. Key Assumptions and Acronyms

Report

Company Profile

  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific, Inc.
  • Illumina, Inc.
  • PerkinElmer, Inc.
  • Crown Bioscience Inc.
  • InSphero, Inc.
  • Merck & Company, Inc.
  • F.Hoffmann-La Roche Ltd.
  • HTG Molecular Diagnostics, Inc.
  • Miltenyi Biotec

Description

Immuno Oncology Assays Market size is valued at USD 2,798.6 million in 2021 and is expected to grow at a prominent growth rate 12.5% during the forecast period 2022 to 2028. The global market provides a detailed overview of the global Immuno Oncology Assays Market, and that can be segmented by Product Type, by Technology, by Indication, and by Application. By product type, the global Immuno Oncology Assays Market has been segmented into Instruments, Reagents and Kits, Software and Services. The software & services segment is likely to be the largest and fastest-growing segment in terms of type. Based on technology, the global Immuno Oncology Assays Market is segmented into Immunoassay, Polymerase chain reaction (PCR), Next-generation sequencing (NGS), Flow Cytometry Others. Among these, the Polymerase chain reaction (PCR) segment is expected to have the fastest-growing market during the forecast period 2022-2028. Based on indication, the global Immuno Oncology Assays Market is segmented into Breast Cancer, Colorectal Cancer, Lung Cancer Treatment, Melanoma Cancer, Bladder Cancer, Others. The lung cancer segment accounts for the largest share in 2021. Breast cancer segment is the second-largest share during the forecast period 2022-2028. Based on the Application, the segment has been segregated into Clinical Diagnostics, Research Application. The clinical diagnostics segment is expected to dominate other segments in the global Immuno Oncology Assays Market. Research application segment is expected to witness the highest CAGR during the forecast period according to precision business insights.

Key Developments:

In July 2020, The HTG EdgeSeq Pan B-Cell Lymphoma Panel was launched by HTG Molecular Diagnostics, Inc. (US).

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX